Startups channel feed – Endpoints News

Startups channel feed

Metagenomi tinkers with pipeline after CSO departure, says Affini-T and Ionis pacts are progressing

9 months ago

Halda adds $126M to test oral drugs for prostate, breast cancer

9 months ago

Exclusive: MIT spinout launches with focus on improving DNA payloads for gene insertion

10 months ago

TPG reveals $580M life sciences fund, which has already backed multiple biotechs

10 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

10 months ago

Arie Belldegrun and team unveil $600M life sciences credit firm amid struggling biotech market

10 months ago

Exclusive: TCG, DCVC and Lux back new autoimmune biotech from Kallyope co-founder

10 months ago

A new Apple Tree Partners biotech launches with $55M to make ‘pan-variant’ antivirals

10 months ago

Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China

10 months ago

Florida CNS gene therapy biotech shuts down

10 months ago

Exclusive: Devoted Health raises $112M, plots insurance markets expansion

10 months ago

Apogee and Spyre founder launches another autoimmune biotech, and it's got $80M to start

10 months ago

PARP biotech backed by more than five pharmas closes after nine years

10 months ago

Exclusive: Ultragenyx secures first funds for Alzheimer's gene therapy spinout

10 months ago

With $144M Series B, Outpace Bio beats funding goal for solid tumor cell therapies

10 months ago

As Amgen pursues GIP antagonism, a Novo Holdings-backed biotech does the same, boosting its Series A

10 months ago

RNA editing startup AIRNA raises $60M for clinical trial in rare liver disease

10 months ago

Behind Boehringer’s up to $1.3B Nerio deal is a budding cancer pipeline and aim to ‘leapfrog AbbVie’

10 months ago

Exclusive: Startup aims to tackle ‘undruggable’ neuro targets with tech from Kevan Shokat's UCSF lab

10 months ago

Boehringer Ingelheim buys oncology biotech for up to $1.3B

10 months ago

In a tough market, private biotechs pursue IPOs and buyouts at the same time

10 months ago

Neurology startup from OrbiMed collab nabs $65M in Series A

10 months ago

At Third Arc Bio, former J&J leaders raise $165M to test oncology, autoimmune biologics

10 months ago

Flagship launches AI-powered biologics biotech with $50M backing

10 months ago

First page Previous page 12 13 141516 17 18 Next page Last page